KaloBios Names New Chairman, Announces Board Changes

KaloBios Pharmaceuticals Inc. said it named Dr. Cameron Durrant as its chairman of the board, after electing him to the board on Jan. 7. Durrant, a former physician, is known as a pharmaceutical company builder and turnaround specialist. He has previously served as chairman, chief executive and chief financial officer for private and public specialty pharma and biotech companies. The company also said Ronald Barliant was elected to its board on Jan. 7, while Michael Harrison has resigned from its board. The stock has remained halted for trading since Dec. 17, when majority owner Martin Shkreli was arrested on fraud charges. KaloBios filed for bankruptcy on Dec. 30.

Copyright © 2016 MarketWatch, Inc.